Mutation analysis of the different tfd genes for degradation of chloroaromatic compounds in Ralstonia eutropha JMP134.
Ralstonia eutropha JMP134 possesses two sets of similar genes for degradation of chloroaromatic compounds, tfdCDEFB (in short: tfdI cluster) and tfdDII CII EII FII BII (tfdII cluster). The significance of two sets of tfd genes for the organism has long been elusive. Here, each of the tfd genes in the two clusters on the original plasmid pJP4 was replaced by double recombination with a gene fragment in which a kanamycin resistance gene was inserted into the respective tfd gene's reading frame. The insertion mutants were all tested for growth on 2,4-dichlorophenoxyacetic acid (2,4-D), 2-methyl-4-chlorophenoxyacetic acid (MCPA), and 3-chlorobenzoate (3-CBA). None of the tfdDII CII EII FII BII genes appeared to be essential for growth on 2,4-D or on 3-CBA. Mutations in tfdC, tfdD and tfdF also did not abolish but only retarded growth on 2,4-D, indicating that they were redundant to some extent as well. Of all tfd genes tested, only tfdE and tfdB were absolutely essential, and interruption of those two reading frames abolished growth on 2,4-D, 3-CBA ( tfdE only), and MCPA completely. Interestingly, strains with insertion mutations in the tfdI cluster and those in tfdDII, tfdCII, tfdEII and tfdBII were severely effected in their growth on MCPA, compared to the wild-type. This indicated that not only the tfdI cluster but also the tfdII cluster has an essential function for R. eutropha during growth on MCPA. In contrast, insertion mutation of tfdDII resulted in better growth of R. eutropha JMP134 on 3-CBA, which is most likely due to the prevention of toxic metabolite production in the absence of TfdDII activity.
Laemmli
Caroline
C
Swiss Federal Institute for Environmental Science and Technology (EAWAG), 8600 Duebendorf, Switzerland.
Werlen
Christoph
C
van der Meer
Jan Roelof
JR
D015084:2,4-Dichlorophenoxyacetic Acid / Q000378:metabolism*; D008456:2-Methyl-4-chlorophenoxyacetic Acid / Q000378:metabolism*; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000235:genetics / Q000502:physiology; D001673:Biodegradation, Environmental; D002265:Carboxylic Ester Hydrolases / Q000235:genetics / Q000502:physiology; D002723:Chlorobenzoates / Q000378:metabolism*; D020118:Cupriavidus necator / Q000187:drug effects / Q000235:genetics* / Q000254:growth & development / Q000378:metabolism*; D049308:Dioxygenases; D024881:Drug Resistance, Bacterial / Q000235:genetics; D023061:Gene Order; D005798:Genes, Bacterial; D019753:Intramolecular Lyases / Q000235:genetics / Q000502:physiology; D007612:Kanamycin / Q000494:pharmacology; D007613:Kanamycin Resistance / Q000235:genetics; D016254:Mutagenesis, Insertional; D009154:Mutation; D010105:Oxygenases / Q000235:genetics / Q000502:physiology; D011995:Recombination, Genetic; D014158:Transcription, Genetic
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D002723:Chlorobenzoates; C036427:3-chlorobenzoic acid; D015084:2,4-Dichlorophenoxyacetic Acid; D007612:Kanamycin; D008456:2-Methyl-4-chlorophenoxyacetic Acid; D010105:Oxygenases; D049308:Dioxygenases; C044173:chlorocatechol 1,2-dioxygenase; D002265:Carboxylic Ester Hydrolases; C046130:carboxymethylenebutenolidase; D019753:Intramolecular Lyases; C055773:chloromuconate cycloisomerase